Article

capitolhilltimes.comcapitolhilltimes.com on 2019-01-07 17:45

Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease

Related news